The NIH-led research response to COVID-19

Science. 2023 Feb 3;379(6631):441-444. doi: 10.1126/science.adf5167. Epub 2023 Feb 2.

¹ National Human Genome Research Institute, Bethesda, MD, USA.
² The Foundation for the National Institutes of Health, North Bethesda, MD, USA.
³ National Center for Advancing Translational Sciences, Bethesda, MD, USA.
⁴ Merck, Rahway, NJ, USA.
⁵ The Janssen Pharmaceutical Companies of Johnson & Johnson, Titusville, NJ, USA.
⁶ National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
⁷ National Heart, Lung, and Blood Institute, Bethesda, MD, USA.
⁸ Teva Pharmaceuticals, Tel Aviv, Israel.
⁹ Pfizer, New York, NY, USA.
¹⁰ National Cancer Institute, Bethesda, MD, USA.
¹¹ US Food and Drug Administration, Silver Spring, MD, USA.
¹² National Institute on Minority Health and Health Disparities, Bethesda, MD, USA.
¹³ Vir Biotechnology, San Francisco, CA, USA.
¹⁴ Office of the Director, National Institutes of Health, Bethesda, MD, USA.
¹⁵ Galapagos, Mechelen, Belgium.
¹⁶ National Institute of Biomedical Imaging and Bioengineering, Bethesda, MD, USA.
¹⁷ Roche, Basel, Switzerland.

Abstract

Investment, collaboration, and coordination have been key.